 |
|
The Burden of Major Depression Avoidable by Longer-term Treatment Strategies
Theo Vos, MD, MSc;
Michelle M. Haby, MAppSc, PhD;
Jan J. Barendregt, MA, PhD;
Michelle Kruijshaar, MSc, PhD;
Justine Corry, MSocSci;
Gavin Andrews, MD
Arch Gen Psychiatry. 2004;61:1097-1103.
Background Major depression is the largest single cause of nonfatal disease burden in Australia. Effective drug and psychological treatments exist, yet are underused.
Objective To quantify the burden of disease currently averted in people seeking care for major depression and the amount of disease burden that could be averted in these people under optimal episodic and maintenance treatment strategies.
Design Modeling impact of current and optimal treatment strategies based on secondary analysis of mental health survey data, studies of the natural history of major depression, and meta-analyses of effectiveness data. Monte Carlo simulation of uncertainty in the model.
Setting The cohort of Australian adults experiencing an episode of major depression in 2000 are modeled through "what if" scenarios of no treatment, current treatment, and optimal treatment strategies with cognitive behavioral therapy or antidepressant drug treatment.
Main Outcome Measure Disability-Adjusted Life Year.
Results Current episodic treatment averts 9% (95% uncertainty interval, 6%-12%) of the disease burden of major depression in Australian adults. Optimal episodic treatment with cognitive behavioral therapy could avert 28% (95% uncertainty interval, 19%-39%) of this disease burden, and with drugs 24% (95% uncertainty interval, 19%-30%) could be averted. During the 5 years after an episode of major depression, current episodic treatment patterns would avert 13% (95% uncertainty interval, 10%-17%) of Disability-Adjusted Life Years, whereas maintenance drug treatment could avert 50% (95% uncertainty interval, 40%-60%) and maintenance cognitive behavioral therapy could avert 52% (95% uncertainty interval, 42%-64%), even if adherence of around 60% is taken into account.
Conclusions Longer-term maintenance drug or psychological treatment strategies are required to make significant inroads into the large disease burden associated with major depression in the Australian population.
Author Affiliations: Department of Human Services, Melbourne, Australia (Drs Vos and Haby); School of Population Health, University of Queensland, Herston, Australia (Drs Vos and Barendregt); Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands (Drs Barendregt and Kruijshaar); and Clinical Research Unit for Anxiety and Depression, University of New South Wales, Sydney, Australia (Ms Corry and Dr Andrews).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Epidemiology of Major Depressive Disorder: Results From the National Epidemiologic Survey on Alcoholism and Related Conditions
Hasin et al.
Arch Gen Psychiatry 2005;62:1097-1106.
ABSTRACT
| FULL TEXT
Treating Depression as Chronic Brings Positive Results
Moran
Psychiatr. News 2004;39:2-33.
FULL TEXT
|
